2171 — CARsgen Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00- HK$6.66bn
- HK$5.18bn
- CNY125.66m
Brief: CARsgen Announces Topline Results From China GC/GEJ Pivotal Phase II Clinical Trial of Claudin18.2 CAR-T
Brief: CARsgen Therapeutics Says Lift Of U.S. Clinical Holds For Products By FDA
Brief: Carsgen Therapeutics Announces Application To Request Lifting Clinical-Holds Submitted To FDA
Brief: Carsgen Therapeutics Says Yijie Concert Purchased 0.33% Stake
Brief: CARsgen Submits Responses To FDA Observations
Brief: Carsgen Therapeutics Responds On Corrective And Preventive Actions Submitted To U.S. FDA
Brief: Carsgen Therapeutics Posts Net Loss Of RMB748 Mln For Year
Brief: CARsgen Therapeutics Says China NMPA Approves BCMA CAR-T Therapy Zevorcabtagene Autoleucel
WuXi Biologics drops on concern over military ties; rivals dip
Brief: Carsgen Therapeutics Says CT011 Achieved Investigational New Drug Clearance From NMPA
Brief: Carsgen Therapeutics Says Yijie Concert Group Intends To Acquire Shares Of Co From Open Market
CARsgen Therapeutics hits record low as some drugs put on clinical hold in US
Brief: Carsgen Therapeutics Says Clinical Hold In U.S. Due To CMC Related Questions
Brief: Carsgen Therapeutics Sys US FDA Granted IND Clearance For CT071
Brief: CARsgen Announces Formation of its Clinical Advisory Board
Brief: CARsgen Therapeutics Posts HY Net Loss Rmb404.5 Million
Brief: Carsgen Therapeutics Collaborates With Moderna
Brief: Carsgen Therapeutics Says AB011 Achieved IND Clearance From NMPA
Brief: Carsgen Therapeutics Holdings Says CT041 Achieved IND Clearance From NMPA